Shaoming Chen
Papers
1
Total Citations
5
H-Index
1
About
Shaoming Chen is a urologic oncologist whose research focuses on optimizing treatment strategies for high-risk prostate cancer, particularly through the integration of neoadjuvant hormone therapy (NHT) with robotic-assisted radical prostatectomy. In his most cited work, Chen demonstrated that administering NHT prior to robotic surgery yields favorable outcomes for patients with aggressive disease, addressing the persistent challenges of positive surgical margins and biochemical recurrence. This study, which has garnered 5 citations, provides critical evidence for refining multimodal approaches in high-risk prostate cancer management. Chen’s contributions lie at the intersection of surgical innovation and neoadjuvant therapeutics, offering a pathway to improve oncologic control while leveraging the precision of robotic techniques. His work underscores a commitment to advancing personalized, evidence-based care for patients facing the most formidable prostate cancer prognoses.
Research Focus
Key Achievements
Top Papers
- 1